CClinicalTrials.gg
CompletedNCT04205448Updated Jan 28, 2021

Fall Prevention Study Among Seniors in Bomlo

An interventional study of Physical exercize in Fall, sponsored by Kjersti Helen Folleso. Completed at 1 site in Norway. Open to participants aged 65 Years to 85 Years. Per ClinicalTrials.gov, last updated 2021-01-28.

Sponsored by Kjersti Helen Folleso · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Mar 2019, registered Dec 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
65 Years to 85 Years
Sex
All
01

Study summary

Recruiting seniors age 65-85 at risk of falling in Bomlo municipality. Clinical tests performed by physiotherapist. If risk of falling is confirmed, participants will be randomized to either intervention group with fall-preventing exercize program or to a control group. Follow-up over 5 years.

Read the detailed description

Participants randomized to either exercise group or control group. Tests for balance and strength performed by physiotherapist at inclusion, and after three and six months and one year for both groups. Further follow-up and further inclusion of participants had to be terminated due to the pandemic in Mach 2020, when group activities were no longer allowed.

02

Conditions studied

  • Fall
03

In context

Lead sponsor

This is the only study on the registry with Kjersti Helen Folleso as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 65-85, home-dwellers in Bomlo municipality, capable of following up group-exercize, informed consent.

Exclusion criteria

Exclusion Criteria:

  • Serious illness, in need of walking-aid indoors, moderate to severe cognitive impairment
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Exercize group

    10 weeks of physical exercise. Testing of strength and balance.

    Behavioral: Physical exercize

  • No intervention
    Control group

    Testing of strength and balance.

Interventions

  • BehavioralPhysical exercize

    10 weeks group exercize followed by community-based voluntary exercize

06

What researchers measure

Primary outcomes

  1. Fall-related injuries

    identified in electronic patient record in primary care

    Time frame: First year

07

Study locations

1 site
  • Bomlo municipality
    Bremnes, Bomlo 5430, Norway
08

References and documents

Individual participant data

Plan to share: Yes — Accepted for publication in Norwegian scientific journal "Utposten".

Supporting information: Study protocol, Csr

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 28, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04205448
Lead sponsor
Kjersti Helen Folleso
Responsible party
Kjersti Helen Folleso (Community physician, Bomlo Municipality) — Sponsor-investigator
First posted
Dec 19, 2019
Start date
Mar 1, 2019
Primary completion
Mar 31, 2020
Completion
Jan 25, 2021
Last update
Jan 28, 2021

Study contacts

Kjetil A Gjoesaeter
study chair · Bomlo Municipality

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion